Discover

News & Info

Quote List Quote List

Aktis Oncology(AKTS.US)

Event Tracking

Mar31

Aktis Oncology released FY2025 earnings on March 30 (EST), actual revenue USD 6.497 M (forecast USD 6.914 M), actual EPS USD 0 (forecast USD -1.9833)

03:00

Aktis Oncology released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 1.87 M (forecast USD 1.233 M), actual EPS USD -18.2125 (forecast USD -1.455)

03:00

Mar4

Aktis Oncology Showcases Strategy for Expanding Targeted Radiotherapy Drugs

01:03

Jan15

Aktis Oncology Inc. Submits Statement Confirming Eli Lilly's 10% Ownership

11:26

Jan14

Ansbert Gadicke Reported Acquisition of Aktis Oncology Inc. Shares

23:18

Jan13

Ecor1 Capital increased its shares in Aktis Oncology to $78.2758 million

02:59

Schedules & Filings

Schedules

Filings

Mar30

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.87 M, Net Income -15.14 M, EPS -18.2125

Dec19

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 933 K, Net Income -12.06 M, EPS -16.0588

Dec18

Ticker Change(EST)

From 12.18 changed to AKTSQ

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More